Global Oral Solid Dosage Medicine Market Growth (Status and Outlook) 2022-2028
Oral drug delivery is the most convenient, high patient compliant, cost effective, and safe route of administration to treat various diseases. Oral solid dosage (OSD) form refers to a final drug product that is ingested through the mouth, dissolved in the digestive system, and delivered to the body through absorption into the bloodstream. The most common OSD forms - tablets and capsules - are efficient and cost-effective to manufacture, shelf stable and easy to administer. They are widely understood and embraced by patients worldwide. They are preferred by pharmaceutical manufacturers owing to the advantage of economy of scale.
The global market for Oral Solid Dosage Medicine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Oral Solid Dosage Medicine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Oral Solid Dosage Medicine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Oral Solid Dosage Medicine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Oral Solid Dosage Medicine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Oral Solid Dosage Medicine players cover Johnson & Johnson, Novartis, Roche, AbbVie and Merck & Co., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Oral Solid Dosage Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Oral Solid Dosage Medicine market, with both quantitative and qualitative data, to help readers understand how the Oral Solid Dosage Medicine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Oral Solid Dosage Medicine market and forecasts the market size by Type (Oral, Injection and Other), by Application (Hospital and Retail Pharmacy.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Oral
Injection
Other
Segmentation by application
Hospital
Retail Pharmacy
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas
Chapter Introduction
Chapter 1: Scope of Oral Solid Dosage Medicine, Research Methodology, etc.
Chapter 2: Executive Summary, global Oral Solid Dosage Medicine market size and CAGR, Oral Solid Dosage Medicine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Oral Solid Dosage Medicine revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Oral Solid Dosage Medicine revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Oral Solid Dosage Medicine market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer and Sanofi, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Solid Dosage Medicine Market Size 2017-2028
2.1.2 Oral Solid Dosage Medicine Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Oral Solid Dosage Medicine Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 Other
2.3 Oral Solid Dosage Medicine Market Size by Type
2.3.1 Oral Solid Dosage Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Oral Solid Dosage Medicine Market Size Market Share by Type (2017-2022)
2.4 Oral Solid Dosage Medicine Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.5 Oral Solid Dosage Medicine Market Size by Application
2.5.1 Oral Solid Dosage Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Oral Solid Dosage Medicine Market Size Market Share by Application (2017-2022)
3 Oral Solid Dosage Medicine Market Size by Player
3.1 Oral Solid Dosage Medicine Market Size Market Share by Players
3.1.1 Global Oral Solid Dosage Medicine Revenue by Players (2020-2022)
3.1.2 Global Oral Solid Dosage Medicine Revenue Market Share by Players (2020-2022)
3.2 Global Oral Solid Dosage Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Oral Solid Dosage Medicine by Regions
4.1 Oral Solid Dosage Medicine Market Size by Regions (2017-2022)
4.2 Americas Oral Solid Dosage Medicine Market Size Growth (2017-2022)
4.3 APAC Oral Solid Dosage Medicine Market Size Growth (2017-2022)
4.4 Europe Oral Solid Dosage Medicine Market Size Growth (2017-2022)
4.5 Middle East & Africa Oral Solid Dosage Medicine Market Size Growth (2017-2022)
5 Americas
5.1 Americas Oral Solid Dosage Medicine Market Size by Country (2017-2022)
5.2 Americas Oral Solid Dosage Medicine Market Size by Type (2017-2022)
5.3 Americas Oral Solid Dosage Medicine Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Solid Dosage Medicine Market Size by Region (2017-2022)
6.2 APAC Oral Solid Dosage Medicine Market Size by Type (2017-2022)
6.3 APAC Oral Solid Dosage Medicine Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oral Solid Dosage Medicine by Country (2017-2022)
7.2 Europe Oral Solid Dosage Medicine Market Size by Type (2017-2022)
7.3 Europe Oral Solid Dosage Medicine Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Solid Dosage Medicine by Region (2017-2022)
8.2 Middle East & Africa Oral Solid Dosage Medicine Market Size by Type (2017-2022)
8.3 Middle East & Africa Oral Solid Dosage Medicine Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Oral Solid Dosage Medicine Market Forecast
10.1 Global Oral Solid Dosage Medicine Forecast by Regions (2023-2028)
10.1.1 Global Oral Solid Dosage Medicine Forecast by Regions (2023-2028)
10.1.2 Americas Oral Solid Dosage Medicine Forecast
10.1.3 APAC Oral Solid Dosage Medicine Forecast
10.1.4 Europe Oral Solid Dosage Medicine Forecast
10.1.5 Middle East & Africa Oral Solid Dosage Medicine Forecast
10.2 Americas Oral Solid Dosage Medicine Forecast by Country (2023-2028)
10.2.1 United States Oral Solid Dosage Medicine Market Forecast
10.2.2 Canada Oral Solid Dosage Medicine Market Forecast
10.2.3 Mexico Oral Solid Dosage Medicine Market Forecast
10.2.4 Brazil Oral Solid Dosage Medicine Market Forecast
10.3 APAC Oral Solid Dosage Medicine Forecast by Region (2023-2028)
10.3.1 China Oral Solid Dosage Medicine Market Forecast
10.3.2 Japan Oral Solid Dosage Medicine Market Forecast
10.3.3 Korea Oral Solid Dosage Medicine Market Forecast
10.3.4 Southeast Asia Oral Solid Dosage Medicine Market Forecast
10.3.5 India Oral Solid Dosage Medicine Market Forecast
10.3.6 Australia Oral Solid Dosage Medicine Market Forecast
10.4 Europe Oral Solid Dosage Medicine Forecast by Country (2023-2028)
10.4.1 Germany Oral Solid Dosage Medicine Market Forecast
10.4.2 France Oral Solid Dosage Medicine Market Forecast
10.4.3 UK Oral Solid Dosage Medicine Market Forecast
10.4.4 Italy Oral Solid Dosage Medicine Market Forecast
10.4.5 Russia Oral Solid Dosage Medicine Market Forecast
10.5 Middle East & Africa Oral Solid Dosage Medicine Forecast by Region (2023-2028)
10.5.1 Egypt Oral Solid Dosage Medicine Market Forecast
10.5.2 South Africa Oral Solid Dosage Medicine Market Forecast
10.5.3 Israel Oral Solid Dosage Medicine Market Forecast
10.5.4 Turkey Oral Solid Dosage Medicine Market Forecast
10.5.5 GCC Countries Oral Solid Dosage Medicine Market Forecast
10.6 Global Oral Solid Dosage Medicine Forecast by Type (2023-2028)
10.7 Global Oral Solid Dosage Medicine Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Oral Solid Dosage Medicine Product Offered
11.1.3 Johnson & Johnson Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Johnson & Johnson Main Business Overview
11.1.5 Johnson & Johnson Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Oral Solid Dosage Medicine Product Offered
11.2.3 Novartis Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Oral Solid Dosage Medicine Product Offered
11.3.3 Roche Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 AbbVie
11.4.1 AbbVie Company Information
11.4.2 AbbVie Oral Solid Dosage Medicine Product Offered
11.4.3 AbbVie Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 AbbVie Main Business Overview
11.4.5 AbbVie Latest Developments
11.5 Merck & Co.
11.5.1 Merck & Co. Company Information
11.5.2 Merck & Co. Oral Solid Dosage Medicine Product Offered
11.5.3 Merck & Co. Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Merck & Co. Main Business Overview
11.5.5 Merck & Co. Latest Developments
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Information
11.6.2 Bristol Myers Squibb Oral Solid Dosage Medicine Product Offered
11.6.3 Bristol Myers Squibb Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bristol Myers Squibb Main Business Overview
11.6.5 Bristol Myers Squibb Latest Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Information
11.7.2 GlaxoSmithKline Oral Solid Dosage Medicine Product Offered
11.7.3 GlaxoSmithKline Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 GlaxoSmithKline Main Business Overview
11.7.5 GlaxoSmithKline Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Oral Solid Dosage Medicine Product Offered
11.8.3 Pfizer Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Oral Solid Dosage Medicine Product Offered
11.9.3 Sanofi Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Oral Solid Dosage Medicine Product Offered
11.10.3 Takeda Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Information
11.11.2 AstraZeneca Oral Solid Dosage Medicine Product Offered
11.11.3 AstraZeneca Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 AstraZeneca Main Business Overview
11.11.5 AstraZeneca Latest Developments
11.12 Bayer
11.12.1 Bayer Company Information
11.12.2 Bayer Oral Solid Dosage Medicine Product Offered
11.12.3 Bayer Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Bayer Main Business Overview
11.12.5 Bayer Latest Developments
11.13 Eli Lilly & Co.
11.13.1 Eli Lilly & Co. Company Information
11.13.2 Eli Lilly & Co. Oral Solid Dosage Medicine Product Offered
11.13.3 Eli Lilly & Co. Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Eli Lilly & Co. Main Business Overview
11.13.5 Eli Lilly & Co. Latest Developments
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Information
11.14.2 Gilead Sciences Oral Solid Dosage Medicine Product Offered
11.14.3 Gilead Sciences Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Gilead Sciences Main Business Overview
11.14.5 Gilead Sciences Latest Developments
11.15 Amgen
11.15.1 Amgen Company Information
11.15.2 Amgen Oral Solid Dosage Medicine Product Offered
11.15.3 Amgen Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Amgen Main Business Overview
11.15.5 Amgen Latest Developments
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Information
11.16.2 Novo Nordisk Oral Solid Dosage Medicine Product Offered
11.16.3 Novo Nordisk Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Novo Nordisk Main Business Overview
11.16.5 Novo Nordisk Latest Developments
11.17 Teva
11.17.1 Teva Company Information
11.17.2 Teva Oral Solid Dosage Medicine Product Offered
11.17.3 Teva Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Teva Main Business Overview
11.17.5 Teva Latest Developments
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Information
11.18.2 Boehringer Ingelheim Oral Solid Dosage Medicine Product Offered
11.18.3 Boehringer Ingelheim Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Boehringer Ingelheim Main Business Overview
11.18.5 Boehringer Ingelheim Latest Developments
11.19 Biogen
11.19.1 Biogen Company Information
11.19.2 Biogen Oral Solid Dosage Medicine Product Offered
11.19.3 Biogen Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Biogen Main Business Overview
11.19.5 Biogen Latest Developments
11.20 Astellas
11.20.1 Astellas Company Information
11.20.2 Astellas Oral Solid Dosage Medicine Product Offered
11.20.3 Astellas Oral Solid Dosage Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Astellas Main Business Overview
11.20.5 Astellas Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Oral Solid Dosage Medicine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Major Players of Other
Table 5. Oral Solid Dosage Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Oral Solid Dosage Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Oral Solid Dosage Medicine Market Size Market Share by Type (2017-2022)
Table 8. Oral Solid Dosage Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Oral Solid Dosage Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Oral Solid Dosage Medicine Market Size Market Share by Application (2017-2022)
Table 11. Global Oral Solid Dosage Medicine Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Oral Solid Dosage Medicine Revenue Market Share by Player (2020-2022)
Table 13. Oral Solid Dosage Medicine Key Players Head office and Products Offered
Table 14. Oral Solid Dosage Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oral Solid Dosage Medicine Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Oral Solid Dosage Medicine Market Size Market Share by Regions (2017-2022)
Table 19. Americas Oral Solid Dosage Medicine Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Oral Solid Dosage Medicine Market Size Market Share by Country (2017-2022)
Table 21. Americas Oral Solid Dosage Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Oral Solid Dosage Medicine Market Size Market Share by Type (2017-2022)
Table 23. Americas Oral Solid Dosage Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Oral Solid Dosage Medicine Market Size Market Share by Application (2017-2022)
Table 25. APAC Oral Solid Dosage Medicine Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Oral Solid Dosage Medicine Market Size Market Share by Region (2017-2022)
Table 27. APAC Oral Solid Dosage Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Oral Solid Dosage Medicine Market Size Market Share by Type (2017-2022)
Table 29. APAC Oral Solid Dosage Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Oral Solid Dosage Medicine Market Size Market Share by Application (2017-2022)
Table 31. Europe Oral Solid Dosage Medicine Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Oral Solid Dosage Medicine Market Size Market Share by Country (2017-2022)
Table 33. Europe Oral Solid Dosage Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Oral Solid Dosage Medicine Market Size Market Share by Type (2017-2022)
Table 35. Europe Oral Solid Dosage Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Oral Solid Dosage Medicine Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Oral Solid Dosage Medicine Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Oral Solid Dosage Medicine Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Oral Solid Dosage Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Oral Solid Dosage Medicine Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Oral Solid Dosage Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Oral Solid Dosage Medicine Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Oral Solid Dosage Medicine
Table 44. Key Market Challenges & Risks of Oral Solid Dosage Medicine
Table 45. Key Industry Trends of Oral Solid Dosage Medicine
Table 46. Global Oral Solid Dosage Medicine Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Oral Solid Dosage Medicine Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Oral Solid Dosage Medicine Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Oral Solid Dosage Medicine Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Oral Solid Dosage Medicine Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Oral Solid Dosage Medicine Market Size Market Share Forecast by Application (2023-2028)
Table 52. Johnson & Johnson Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 53. Johnson & Johnson Oral Solid Dosage Medicine Product Offered
Table 54. Johnson & Johnson Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Johnson & Johnson Main Business
Table 56. Johnson & Johnson Latest Developments
Table 57. Novartis Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 58. Novartis Oral Solid Dosage Medicine Product Offered
Table 59. Novartis Main Business
Table 60. Novartis Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Novartis Latest Developments
Table 62. Roche Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 63. Roche Oral Solid Dosage Medicine Product Offered
Table 64. Roche Main Business
Table 65. Roche Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Roche Latest Developments
Table 67. AbbVie Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 68. AbbVie Oral Solid Dosage Medicine Product Offered
Table 69. AbbVie Main Business
Table 70. AbbVie Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. AbbVie Latest Developments
Table 72. Merck & Co. Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 73. Merck & Co. Oral Solid Dosage Medicine Product Offered
Table 74. Merck & Co. Main Business
Table 75. Merck & Co. Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Merck & Co. Latest Developments
Table 77. Bristol Myers Squibb Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 78. Bristol Myers Squibb Oral Solid Dosage Medicine Product Offered
Table 79. Bristol Myers Squibb Main Business
Table 80. Bristol Myers Squibb Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Bristol Myers Squibb Latest Developments
Table 82. GlaxoSmithKline Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 83. GlaxoSmithKline Oral Solid Dosage Medicine Product Offered
Table 84. GlaxoSmithKline Main Business
Table 85. GlaxoSmithKline Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. GlaxoSmithKline Latest Developments
Table 87. Pfizer Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 88. Pfizer Oral Solid Dosage Medicine Product Offered
Table 89. Pfizer Main Business
Table 90. Pfizer Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Pfizer Latest Developments
Table 92. Sanofi Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 93. Sanofi Oral Solid Dosage Medicine Product Offered
Table 94. Sanofi Main Business
Table 95. Sanofi Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Sanofi Latest Developments
Table 97. Takeda Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 98. Takeda Oral Solid Dosage Medicine Product Offered
Table 99. Takeda Main Business
Table 100. Takeda Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Takeda Latest Developments
Table 102. AstraZeneca Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 103. AstraZeneca Oral Solid Dosage Medicine Product Offered
Table 104. AstraZeneca Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. AstraZeneca Main Business
Table 106. AstraZeneca Latest Developments
Table 107. Bayer Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 108. Bayer Oral Solid Dosage Medicine Product Offered
Table 109. Bayer Main Business
Table 110. Bayer Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Bayer Latest Developments
Table 112. Eli Lilly & Co. Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 113. Eli Lilly & Co. Oral Solid Dosage Medicine Product Offered
Table 114. Eli Lilly & Co. Main Business
Table 115. Eli Lilly & Co. Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Eli Lilly & Co. Latest Developments
Table 117. Gilead Sciences Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 118. Gilead Sciences Oral Solid Dosage Medicine Product Offered
Table 119. Gilead Sciences Main Business
Table 120. Gilead Sciences Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Gilead Sciences Latest Developments
Table 122. Amgen Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 123. Amgen Oral Solid Dosage Medicine Product Offered
Table 124. Amgen Main Business
Table 125. Amgen Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Amgen Latest Developments
Table 127. Novo Nordisk Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 128. Novo Nordisk Oral Solid Dosage Medicine Product Offered
Table 129. Novo Nordisk Main Business
Table 130. Novo Nordisk Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. Novo Nordisk Latest Developments
Table 132. Teva Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 133. Teva Oral Solid Dosage Medicine Product Offered
Table 134. Teva Main Business
Table 135. Teva Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 136. Teva Latest Developments
Table 137. Boehringer Ingelheim Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 138. Boehringer Ingelheim Oral Solid Dosage Medicine Product Offered
Table 139. Boehringer Ingelheim Main Business
Table 140. Boehringer Ingelheim Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 141. Boehringer Ingelheim Latest Developments
Table 142. Biogen Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 143. Biogen Oral Solid Dosage Medicine Product Offered
Table 144. Biogen Main Business
Table 145. Biogen Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 146. Biogen Latest Developments
Table 147. Astellas Details, Company Type, Oral Solid Dosage Medicine Area Served and Its Competitors
Table 148. Astellas Oral Solid Dosage Medicine Product Offered
Table 149. Astellas Main Business
Table 150. Astellas Oral Solid Dosage Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 151. Astellas Latest Developments
List of Figures
List of Figures
Figure 1. Oral Solid Dosage Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral Solid Dosage Medicine Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Oral Solid Dosage Medicine Market Size Market Share by Type in 2021
Figure 7. Oral Solid Dosage Medicine in Hospital
Figure 8. Global Oral Solid Dosage Medicine Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Oral Solid Dosage Medicine in Retail Pharmacy
Figure 10. Global Oral Solid Dosage Medicine Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. Global Oral Solid Dosage Medicine Market Size Market Share by Application in 2021
Figure 12. Global Oral Solid Dosage Medicine Revenue Market Share by Player in 2021
Figure 13. Global Oral Solid Dosage Medicine Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Oral Solid Dosage Medicine Market Size 2017-2022 ($ Millions)
Figure 15. APAC Oral Solid Dosage Medicine Market Size 2017-2022 ($ Millions)
Figure 16. Europe Oral Solid Dosage Medicine Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Oral Solid Dosage Medicine Market Size 2017-2022 ($ Millions)
Figure 18. Americas Oral Solid Dosage Medicine Value Market Share by Country in 2021
Figure 19. Americas Oral Solid Dosage Medicine Consumption Market Share by Type in 2021
Figure 20. Americas Oral Solid Dosage Medicine Market Size Market Share by Application in 2021
Figure 21. United States Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Oral Solid Dosage Medicine Market Size Market Share by Region in 2021
Figure 26. APAC Oral Solid Dosage Medicine Market Size Market Share by Application in 2021
Figure 27. China Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Oral Solid Dosage Medicine Market Size Market Share by Country in 2021
Figure 34. Europe Oral Solid Dosage Medicine Market Size Market Share by Type in 2021
Figure 35. Europe Oral Solid Dosage Medicine Market Size Market Share by Application in 2021
Figure 36. Germany Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Oral Solid Dosage Medicine Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Oral Solid Dosage Medicine Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Oral Solid Dosage Medicine Market Size Market Share by Application in 2021
Figure 44. Egypt Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Oral Solid Dosage Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 50. APAC Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 51. Europe Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 53. United States Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 54. Canada Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 57. China Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 58. Japan Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 59. Korea Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 61. India Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 62. Australia Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 63. Germany Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 64. France Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 65. UK Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 66. Italy Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 67. Russia Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 68. Spain Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 71. Israel Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Oral Solid Dosage Medicine Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets